Osteoarthritis Clinical Trial
— MenTOROfficial title:
Does the Biological Response to Degenerative Meniscal Tears or to Their Intervention Predict Future Osteoarthritis?: The Meniscal Tear and Osteoarthritis Risk (MenTOR) Study
| Verified date | November 2020 |
| Source | University of Oxford |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Adults with degenerative meniscal tear receiving arthroscopic surgical management or knee drainage (arthrocentesis) +/- intra-articular steroid injection will be recruited to this non-interventional cohort study. The aim is to investigate whether measurement of an individual's synovial fluid biomarker response to a degenerative meniscal tear with symptoms predicts symptomatic and functional outcome suggestive of osteoarthritis (OA) of the knee.
| Status | Active, not recruiting |
| Enrollment | 150 |
| Est. completion date | February 2026 |
| Est. primary completion date | February 2023 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 30 Years to 60 Years |
| Eligibility | Inclusion Criteria: 1. Male or female aged 30-60 years. 2. Participant able and willing to give informed consent. 3. Clinical assessment demonstrates mechanical symptoms suggestive of meniscal pathology (focal knee pain +/- 1 or more of: catching/locking, giving way, focal joint-line tenderness, effusion, McMurray's positive) within last 12 months. 4. Evidence on clinical MRI knee of meniscal tear. 5. Participant is either in secondary care or has the potential to be referred to secondary care due to severity of symptoms. 6. Patient has failed conservative therapy and elected for surgical arthroscopic treatment, or is due knee drainage/injection for clinical reasons. 7. Competency of the English language to complete questionnaires independently. Exclusion Criteria: 1. Pre-existing advanced radiographic OA (KL grade 3-4) of index knee at baseline. 2. Evidence of anterior cruciate ligament rupture, or more extensive soft tissue injury. 3. History of an acute knee injury (within 12 weeks), or acutely locked knee 4. Known history of inflammatory/septic arthritis of index knee. 5. Knee replacement or other non-arthroscopic knee surgery (e.g. high tibial osteotomy) - previous or planned within 1 year of study start. 6. Index knee surgery within last 3 months, including meniscectomy. 7. Steroid injection to index knee in last 3 months. 8. Active other (treated) inflammatory disease or infection. 9. Positive pregnancy test. 10. Unable to provide blood samples. 11. Unable to give informed written consent. |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Kennedy Insitute of Rheumatololgy, NDORMS, University of Oxford | Oxford | Oxfordshire |
| Lead Sponsor | Collaborator |
|---|---|
| University of Oxford | Oxford University Hospitals NHS Trust |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Knee Injury and Osteoarthritis Outcomes Score (KOOS)-4 | summary score from validated KOOS questionnaire. To investigate whether measurement of an individual's synovial fluid biomarker response to a degenerative meniscal tear with symptoms predicts symptomatic and functional outcome suggestive of OA of the knee. | 2 years | |
| Secondary | X ray Kellgren Lawrence (KL) change | X ray of knee.Change in KL grade over time will be measured. | 2 years | |
| Secondary | MRI semi-quantitative score | MRI knee. Change in semi-quantitative score over time will be measured. | 2 years | |
| Secondary | Oxford Knee Score - Activity and Participation Questionnaire (OKS-APQ) | The OKS-APQ will be used to document pain and symptoms, and compared with KOOS. | 2 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04657926 -
A Trial of APPA in the Treatment of Knee Osteoarthritis
|
Phase 2 | |
| Completed |
NCT02536833 -
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
|
Phase 2 | |
| Completed |
NCT03014037 -
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
|
N/A | |
| Recruiting |
NCT05937542 -
A Qualitative Investigation of CLEAT Participants
|
||
| Completed |
NCT03644615 -
A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis
|
N/A | |
| Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
| Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03850665 -
Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach
|
N/A | |
| Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
| Completed |
NCT04402502 -
Dynamic 4DCT to Examine Wrist Carpal Mechanics
|
N/A | |
| Completed |
NCT02923700 -
Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT04564053 -
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
|
Phase 1 | |
| Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
| Not yet recruiting |
NCT05036174 -
Diphenhydramine Ointment for Knee Osteoarthritis
|
N/A | |
| Recruiting |
NCT02666443 -
Low Dose Dexamethasone in Supraclavicular Blocks
|
N/A | |
| Recruiting |
NCT02912429 -
Onlay vs. Inlay Patellofemoral Arthroplasty
|
N/A | |
| Active, not recruiting |
NCT02723929 -
Effects of tDCS and tUS on Pain Perception in OA of the Knee
|
||
| Withdrawn |
NCT02921594 -
Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties
|
N/A | |
| Terminated |
NCT02820766 -
Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
|
N/A |